Orsini and Dos Rx Join Forces to Enhance Medical Travel for Patients

In a significant move aimed at improving the international medical travel experience for patients, Orsini, a prominent provider of pharmacy solutions for rare diseases, has announced a partnership with Dos Rx, a global leader in facilitating medical travel logistics. The collaboration seeks to streamline access to essential therapies for medical travelers receiving care in the United States. As the complexity of healthcare continues to rise, ensuring that international patients have uninterrupted access to the medications they need is more important than ever.

Dos Rx plays a crucial role in this partnership by offering fully integrated pharmacy services and optimizing pharmacy logistics to simplify the medication access for international patients. With this joint effort, the two organizations aspire to eliminate barriers that medical travelers face, particularly those requiring complex treatments.

Tim Whitaker, the Founder and CEO of Dos Rx, noted that navigating healthcare can pose considerable challenges for international patients. He emphasized the mission of Dos Rx to minimize these hurdles. “Pharmacy shouldn't add to the complexity,” Whitaker stated. “With Orsini’s extensive knowledge in rare disease therapies, we can ensure that every patient is able to obtain the transformative medications required during their healthcare journey in the U.S.”

Through this partnership, patients traveling to the U.S. for treatment will benefit from a seamless and cost-effective approach to pharmaceutical care. This collaboration aims to make pharmaceutical services more accessible, inclusive, and responsive to the needs of diverse patients.

Brandon Tom, Chief Executive Officer of Orsini, expressed his enthusiasm for the partnership, stating, “Our mission is to guarantee that no patient is overlooked. Partnering with Dos Rx expands our reach to assist even more patients.” He highlighted the effectiveness of combining Orsini's patient-centric care model with Dos Rx's logistical support capabilities. Together, they aim to enhance the healthcare experience for individuals suffering from rare diseases who seek treatment in foreign countries.

About Orsini

Established in 1987, Orsini has been a leader in providing comprehensive and compassionate care for patients with rare diseases and gene therapies. They collaborate with biopharmaceutical innovators, healthcare providers, and payors to help patients and their families access groundbreaking treatments tailored to their unique needs. By employing integrated pharmacy solutions that encompass distribution, patient services, clinical management, and home infusion services, Orsini makes it easier for patients to connect with essential therapies.

Orsini's commitment to high-quality care is reflected in its extensive range of accreditations, including from the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC, and the NABP. They have also garnered recognition in the form of the Rare Disease Pharmacy Center of Excellence Certification from URAC.

About Dos Rx

Dos Rx stands out as a leader in the realm of international medical travel and pharmacy innovation. It offers a wide range of pharmacy services meticulously designed for patients seeking complex medical care in the United States. As a facilitator of pharmacy logistics, Dos Rx ensures that both government-sponsored programs and self-insured patients can access medications without unnecessary delays, fostering a health system that is not only cost-effective but also languagesensitive and accessible to all.

With strategic alliances with select pharmacy partners, Dos Rx is dedicated to enhancing patient outcomes while concurrently reducing healthcare costs for entities supporting patients worldwide. Their commitment to innovation in pharmacy services continues to set benchmarks for excellence in patient care.

By combining forces, Orsini and Dos Rx are set to revolutionize the medical travel experience for countless patients who rely on timely access to vital therapies as they seek treatment in the U.S., truly embodying the philosophy that every patient deserves the best possible care, no matter where they are from.